The European Union has given medical authorization to it's 1st long acting HIV treatment. According to this piece, Vocabria, also know as Cabotegravir from ViiV healthcare & Janssen Pharmaceutical, has been given clearance to move ahead with once monthly injections.
The treatment starts in a traditional manner with daily tablets for a month, to determine tolerance to the meds. After, the dosage would switch to once monthly injections. The company is in the process of developing an injection that would be taken every 2 months. I'd assume the process would be the same; tablets, single month injection & the longer lasting dose.
This could change the HIV game. It could mean oral meds are heading out of the top tier position. Patients would have to see a medical professional for the injections. There'd be more contact with those needing medical care.
That's all for now, take care.
Cya...
No comments:
Post a Comment